Dalantercept plus axitinib fails to improve progression-free survival in people with kidney cancer
The development of dalantercept, an anaplastic lymphoma kinase 1 (ALK1) [...]
The development of dalantercept, an anaplastic lymphoma kinase 1 (ALK1) [...]
This paper, published in the online Practice Update journal Renal [...]
Results from an early phase Ib clinical trial of avelumab [...]
In this video interview, Dr Shilpa Gupta, assistant professor, Haematology, [...]
Results from the first part of the phase 2 DART [...]
TRACON Pharmaceuticals presented final results from a phase 1b clinical trial combining [...]